Nuclear localisation of the G-actin sequestering peptide thymosin beta4.
Huff. Thomas T; Rosorius. Olaf O; Otto. Angela M AM; Müller. Christian S G CS; Ballweber. Edda E; Hannappel. Ewald E; Mannherz. Hans Georg HG
Key Findings
- Fluorescently labelled thymosin‑beta‑4 shows both cytoplasmic and strong nuclear staining after microinjection.
- Only the larger N‑terminal fragment of the peptide localises to the nucleus; the C‑terminal fragment remains cytoplasmic.
- Nuclear entry requires an active transport mechanism and a soluble cytoplasmic factor, as shown by permeabilisation experiments.
Practical Outcomes
- At present there are no direct protocols or dosage recommendations for biohackers. The discovery highlights a possible nuclear role for thymosin‑beta‑4, which could become relevant if future research links this activity to health benefits such as tissue repair or anti‑aging effects.
Summary
Scientists found that the small protein thymosin‑beta‑4 can move from the cell’s fluid into the nucleus using an active transport system, and that only its front half (the N‑terminal part) goes into the nucleus while the back half stays in the cytoplasm. This suggests the peptide might also bind actin inside the nucleus, hinting at unknown nuclear functions.
Abstract
Thymosin beta4 is regarded as the main G-actin sequestering peptide in the cytoplasm of mammalian cells. It is also thought to be involved in cellular events like cancerogenesis, apoptosis, angiogenesis, blood coagulation and wound healing. Thymosin beta4 has been previously reported to localise intracellularly to the cytoplasm as detected by immunofluorescence. It can be selectively labelled at two of its glutamine-residues with fluorescent Oregon Green cadaverine using transglutaminase; however, this labelling does not interfere with its interaction with G-actin. Here we show that after microinjection into intact cells, fluorescently labelled thymosin beta4 has a diffuse cytoplasmic and a pronounced nuclear staining. Enzymatic cleavage of fluorescently labelled thymosin beta4 with AsnC-endoproteinase yielded two mono-labelled fragments of the peptide. After microinjection of these fragments, only the larger N-terminal fragment, containing the proposed actin-binding sequence exhibited nuclear localisation, whereas the smaller C-terminal fragment remained confined to the cytoplasm. We further showed that in digitonin permeabilised and extracted cells, fluorescent thymosin beta4 was solely localised within the cytoplasm, whereas it was found concentrated within the cell nuclei after an additional Triton X100 extraction. Therefore, we conclude that thymosin beta4 is specifically translocated into the cell nucleus by an active transport mechanism, requiring an unidentified soluble cytoplasmic factor. Our data furthermore suggest that this peptide may also serve as a G-actin sequestering peptide in the nucleus, although additional nuclear functions cannot be excluded.
Study Information
pubmed
2004
2004-10-05T00:00:00.000Z
10.1242/jcs.01404
93
76